This protocol is judged by an institutional assessment board, an independent group that testimonials any clinical trials involving human beings. If a review consists of a Timetable I drug, after the board approves the protocol as moral, the scientists really have to make an application for an investigational new drug (IND) quantity in the FDA.As a